SCM
DVAX

Soleus Capital Management’s Dynavax Technologies DVAX Stock Holding History

Soleus Capital Management’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-167,798
Closed -$725K – 70
2020
Q3 		$725K Buy
167,798
+67,798
+68% +$484K 0.38% 51
2020
Q2 		$887K Buy
+100,000
New +$505K 0.51% 43

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Soleus Capital Management's DVAX Position: Q4 2020 in Review

Soleus Capital Management sold out of Dynavax Technologies (DVAX) in Q4 2020, closing a stake of 167,798 shares — an estimated $725K sold.

Soleus Capital Management first reported a position in DVAX in Q2 2020 and held it in 2 quarters. The position peaked at $887K in Q2 2020. 144 funds tracked by Wall St. Rank hold DVAX as of Q4 2020.

  • Soleus Capital Management reported no remaining Dynavax Technologies position as of Q4 2020 after selling out during the quarter.
  • Soleus Capital Management sold 167,798 Dynavax Technologies shares in Q4 2020, an estimated $725K.
  • Soleus Capital Management first reported a position in Dynavax Technologies in Q2 2020 and held it in 2 quarters.
  • Soleus Capital Management's Dynavax Technologies position peaked at $887K in Q2 2020.
  • 144 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2020.

Based on Soleus Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.